MedTrace Logo

RSYR for Fatigue Reduction in Cancer Survivors

NCT03911921 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2019-04-16

No results posted yet for this study

Summary

This randomized Phase II trial to establish the efficacy of traditional Chinese medicine (TCM) herbal products above control group for treating fatigue in patients with cancer.

Conditions

  • Cancer-related Problem/Condition

Interventions

DRUG

RSYRT decoction

Compound granules of traditional Chinese medicine

DRUG

Astragalus membranaceus

One herb

Sponsors & Collaborators

  • Peking University Cancer Hospital & Institute

    lead OTHER

Principal Investigators

  • Pingping Li, Prof. · Peking University Cancer Hospital & Institute

  • Ting Lu, Dr. · Peking University Cancer Hospital & Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-01
Primary Completion
2019-02-01
Completion
2019-02-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03911921 on ClinicalTrials.gov